Navigation Links
Initial Data from Lightlake Therapeutics Joint Clinical Trial with NIDA Shows Nasal Delivery of Naloxone for Opioid Overdose as a Promising Treatment
Date:12/3/2013

approval and launch of our product, we expect significant market demand given the growing opioid addiction epidemic and the multiple substantial advantages of our intranasal delivery of naloxone over the current injectable delivery of naloxone."

About Lightlake Therapeutics

Lightlake Therapeutics Inc., a London-based biopharmaceutical company, is using its expertise in opioid antagonists to build a platform of innovative solutions to common addictions and related disorders. The Company holds patents covering the use of intranasal naloxone to treat Binge Eating Disorder ("BED") as well as patents covering addiction to drugs including cocaine, amphetamine, and MDMA. Lightlake is currently focused on advancing its treatment for BED, which has successfully completed Phase II clinical trials, and a Phase II trial is planned for the indication of Bulimia Nervosa. Lightlake is also applying its technology to develop a treatment for managing the complications of opioid drug addiction in collaboration with the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health. For more information please visit: http://www.lightlaketherapeutics.com

Forward Looking Statement

This press release contains forward-looking statements. These statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our or our industry's actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed, implied or inferred by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "could," "would," "expects," "plans," "intends," "anticipates," "believes," estimates," "predicts," "proj
'/>"/>

SOURCE Lightlake Therapeutics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Initial Studies of Channel Medsystems Cryothermic Therapy Demonstrate Preliminary Safety and Tolerability; Results Presented at the 42nd AAGL Global Congress
2. Montage Healthcare and Mammography Reporting Systems to show initial results of partnership to enrich mammography quality efforts at RSNA 2013
3. Tandem Diabetes Care Announces Closing of Initial Public Offering
4. Tandem Diabetes Care Announces Exercise of Option to Purchase Additional Shares in Initial Public Offering of Common Stock
5. Epizymes EPZ-5676 DOT1L Inhibitor Demonstrates Encouraging Initial Findings in an Ongoing Phase 1 Dose Escalation Study
6. Tandem Diabetes Care Prices Initial Public Offering
7. American Red Cross Contributes an Initial $6 Million to Support Typhoon Haiyan Response Efforts in Philippines
8. Cara Therapeutics Files Registration Statement for Proposed Initial Public Offering
9. Veracyte, Inc. Announces Pricing of Initial Public Offering
10. Genocea Reports Positive Initial Phase 1/2a Results for GEN-003, its Pioneering Therapeutic Vaccine Candidate for the Treatment of Herpes Simplex Virus-2 (HSV-2), at ICAAC 2013
11. Regado Biosciences, Inc. Announces Closing of Initial Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... -- Just days before the government of Sierra ... spread of Ebola, World Vision will begin a massive delivery ... private donations. McKesson, the largest healthcare services company ... affiliate McKesson Medical-Surgical donated four million pairs of latex gloves ... Sierra Leone,s needs for the next five months* ...
(Date:9/18/2014)... VIEW, Calif. and CHESTERBROOK, Pa. ... (Nasdaq: VVUS ) and Auxilium Pharmaceuticals, Inc. ... U.S. Food and Drug Administration (FDA) has approved a supplemental ... is now the only FDA-approved erectile dysfunction (ED) medication indicated ... sexual activity. STENDRA is a prescription medication in ...
(Date:9/17/2014)... Sept. 17, 2014 /PRNewswire-iReach/ -- DeepResearchReports.com adds "2014 ... Industry" and "2014 Market Research Report on Global ... its store. Photo - http://photos.prnewswire.com/prnh/20140917/146748 ... on Global Methyl Methacrylate (MMA) Industry" is a ... China and Global Methyl Methacrylate (MMA) ...
Breaking Medicine Technology:World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 2World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 3World Vision, McKesson, Other Donors Prepare for Massive Shipment of Medical Supplies to Support Sierra Leone Health Workers 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 2VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 3VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 4VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 5VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 6VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 7VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 8VIVUS And Auxilium Announce FDA Approval Of STENDRA sNDA; STENDRA Now First And Only Oral Erectile Dysfunction Treatment Approved To Be Taken Approximately 15 Minutes Before Sexual Activity 9Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 2Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 3Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 4Methyl Methacrylate Market & Chinese Isothiocyanate Industry Trend Development 5
(Date:9/18/2014)... Clinical trial report, “Edema Global Clinical ... clinical trial scenario. This report provides elemental information and ... includes an overview of the trial numbers and their ... across the globe. The databook offers a preliminary coverage ... prominence of the sponsors and also provides briefing pertaining ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Phela Health ... the HABIT™ Program in South Africa. HABIT™ ... and Wellness, and distributed in South Africa by Bestflex. ... HABIT program, which has been tailored to address issues ... focuses on behavior modification and chronic disease prevention. This ...
(Date:9/18/2014)... eat more vegetables and drink less sugar, according to ... But it,s still not enough, the study goes on ... it comes to eating healthier at school , The ... socioeconomic status, may inform a child,s diet. , The ... post-secondary education were 85 per cent more likely to ...
(Date:9/18/2014)... rates in Spain of newborns with a gestational age under ... is ,exceptional, although other factors such as birth weight and ... Society of Neonatology have studied the survival rates in Spain ... into account that a newborn carried to term is between ... from the national database that gathers information on all babies ...
(Date:9/18/2014)... NY (PRWEB) September 18, 2014 According to ... Products and Services Market - Global Industry Analysis, Size, Share, ... products and services market was valued at USD 77607.7 million ... of 5.9% from 2014 to 2020, to reach an estimated ... dialysis products and services market is growing at a rapid ...
Breaking Medicine News(10 mins):Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 2Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 3Health News:Edema Therapeutics Clinical Trials Market 2014 Review Report Available at MarketOptimizer.org 4Health News:Kids eat better if their parents went to college 2Health News:The viability of premature babies is minimal at 22 weeks' gestation 2Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 2Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 3Health News:Dialysis Products and Services Market Expected to Reach USD 115.4 Billion Globally in 2020 4
... on Hair Research will be convened in Vancouver from June ... experts, with clinicians and scientists examining many aspects of ... thin or thick, loosing hair can weaken a person emotionally. ... can also influence career advancement and emotional well being, adds ...
... , So shines a good deed in a weary world' ... is celebrated universally as the 'World Blood Donor Day' . It ... discovered the ABO blood group system. ,World ... Day, 2000, which was devoted to the theme 'Blood Saves Lives. ...
... Eraxis, known generically as anidulafungin was shown to be ... a potentially fatal blood infection seen in people ... to a research by Dr. Annette Reboli of Cooper ... published their findings in the New England Journal of ...
... help keep depression at bay. The study that was conducted ... up with the benefits of the major constituents of cod ... examining the dietary habits and health of about 22,000 subjects ... never took cod liver oil had higher rates of depression, ...
... alternative system of medicine, are continuing their protest here in ... ,The system treats diseases through the use of electricity. ... for over two months, complain that the authorities have not ... also want to meet Chief Minister Ghulam Nabi Azad with ...
... at the University of Virginia Health System have discovered ... restore hearing, into diseased tissue of the human inner ... curing genetic or acquired hearing loss. ,Dr. ... UVa, and his research team, including Dr. Bradley Kesser, ...
Cached Medicine News:Health News:World Largest Hair Congress Convene in Vancouver 2Health News:World Blood Donor Day 2Health News:New Anti Fungal Drug Eraxis as Good as the Older Medicine 2
Inquire...
Inquire...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave ... support • Select options like seats, ... • BTP/1Q-PAL chairs are recommended for ... clean room, static control, health care ...
Medicine Products: